ResearcherUniversity of LiverpoolActive in the last 2 years
Robert Peter Jones
Matched on ORCID iD 0000-0001-5608-001X; OpenAlex author ID A5018454853. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 35
2017: 1 paper · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: none · 2024: 3 papers
Papers 7
- Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis. Co-author DOI 10.1038/s43018-024-00731-2↗
- Author Correction: Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis. Co-author DOI 10.1038/s43018-024-00751-y↗
- Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis. Co-author DOI 10.1158/0008-5472.can-23-1542↗
- Chemotherapy-induced infiltration of neutrophils promotes pancreatic cancer metastasis via Gas6/AXL signalling axis. Co-author DOI 10.1136/gutjnl-2021-325272↗
- Recurrence After Resection of Pancreatic Ductal Adenocarcinoma-Reply. First author DOI 10.1001/jamasurg.2019.5465↗
- Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomized Adjuvant Chemotherapy Trial. Co-author DOI 10.1001/jamasurg.2019.3337↗
- Immunohistochemical hENT1 expression as a prognostic biomarker in patients with resected pancreatic ductal adenocarcinoma undergoing adjuvant gemcitabine-based… Co-author DOI 10.1002/bjs.10482↗
Closest collaborators
The 25 strongest of 35 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Paula Ghaneh · 6 shared papers, 2017–2024 · strength 0.79
- Paper Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis. DOI 10.1158/0008-5472.can-23-1542↗
- Paper Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis. DOI 10.1038/s43018-024-00731-2↗
- Paper Author Correction: Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis. DOI 10.1038/s43018-024-00751-y↗
- Christopher Michael Halloran · 5 shared papers, 2019–2024 · strength 0.73
- Paper Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis. DOI 10.1158/0008-5472.can-23-1542↗
- Paper Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis. DOI 10.1038/s43018-024-00731-2↗
- Paper Author Correction: Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis. DOI 10.1038/s43018-024-00751-y↗
- Michael C. Schmid · 4 shared papers, 2022–2024 · strength 0.67
- Paper Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis. DOI 10.1158/0008-5472.can-23-1542↗
- Paper Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis. DOI 10.1038/s43018-024-00731-2↗
- Paper Author Correction: Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis. DOI 10.1038/s43018-024-00751-y↗
- Ainhoa Mielgo Iza · 4 shared papers, 2022–2024 · strength 0.67
- Paper Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis. DOI 10.1158/0008-5472.can-23-1542↗
- Paper Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis. DOI 10.1038/s43018-024-00731-2↗
- Paper Author Correction: Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis. DOI 10.1038/s43018-024-00751-y↗
- Gaia Bellomo · 4 shared papers, 2022–2024 · strength 0.67
- Paper Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis. DOI 10.1158/0008-5472.can-23-1542↗
- Paper Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis. DOI 10.1038/s43018-024-00731-2↗
- Paper Author Correction: Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis. DOI 10.1038/s43018-024-00751-y↗
- Daniel H. Palmer · 5 shared papers, 2017–2024 · strength 0.59
- Paper Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis. DOI 10.1038/s43018-024-00731-2↗
- Paper Author Correction: Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis. DOI 10.1038/s43018-024-00751-y↗
- Paper Chemotherapy-induced infiltration of neutrophils promotes pancreatic cancer metastasis via Gas6/AXL signalling axis. DOI 10.1136/gutjnl-2021-325272↗
- Valeria Quaranta · 3 shared papers, 2022–2024 · strength 0.47
- Paper Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis. DOI 10.1038/s43018-024-00731-2↗
- Paper Author Correction: Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis. DOI 10.1038/s43018-024-00751-y↗
- Paper Chemotherapy-induced infiltration of neutrophils promotes pancreatic cancer metastasis via Gas6/AXL signalling axis. DOI 10.1136/gutjnl-2021-325272↗
- Yuliana Astuti · 3 shared papers, 2022–2024 · strength 0.47
- Paper Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis. DOI 10.1038/s43018-024-00731-2↗
- Paper Author Correction: Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis. DOI 10.1038/s43018-024-00751-y↗
- Paper Chemotherapy-induced infiltration of neutrophils promotes pancreatic cancer metastasis via Gas6/AXL signalling axis. DOI 10.1136/gutjnl-2021-325272↗
- Meirion Raymant Raymant · 3 shared papers, 2022–2024 · strength 0.47
- Paper Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis. DOI 10.1038/s43018-024-00731-2↗
- Paper Author Correction: Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis. DOI 10.1038/s43018-024-00751-y↗
- Paper Chemotherapy-induced infiltration of neutrophils promotes pancreatic cancer metastasis via Gas6/AXL signalling axis. DOI 10.1136/gutjnl-2021-325272↗
- Jennifer P. Morton · 3 shared papers, 2022–2024 · strength 0.47
- Paper Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis. DOI 10.1038/s43018-024-00731-2↗
- Paper Author Correction: Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis. DOI 10.1038/s43018-024-00751-y↗
- Paper Chemotherapy-induced infiltration of neutrophils promotes pancreatic cancer metastasis via Gas6/AXL signalling axis. DOI 10.1136/gutjnl-2021-325272↗
- John P. Neoptolemos · 3 shared papers, 2017–2020 · strength 0.31
- Paper Recurrence After Resection of Pancreatic Ductal Adenocarcinoma-Reply. DOI 10.1001/jamasurg.2019.5465↗
- Paper Immunohistochemical hENT1 expression as a prognostic biomarker in patients with resected pancreatic ductal adenocarcino… DOI 10.1002/bjs.10482↗
- Paper Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomi… DOI 10.1001/jamasurg.2019.3337↗
- Markus Wolfgang Büchler · 2 shared papers, 2019–2020 · strength 0.25
- Teifion Luckett · 1 shared paper, 2024 · strength 0.20
- Mark A. Glenn · 1 shared paper, 2024 · strength 0.20
- Lucy Ireland · 1 shared paper, 2024 · strength 0.20
- Carolyn Rainer · 1 shared paper, 2022 · strength 0.13
- N. Bird · 1 shared paper, 2017 · strength 0.06
- William Greenhalf · 1 shared paper, 2017 · strength 0.06
- Gary Middleton · 1 shared paper, 2019 · strength 0.06
- Alan Anthoney · 1 shared paper, 2019 · strength 0.06
- Olusola Olusesan Faluyi · 1 shared paper, 2019 · strength 0.06
- Yuk Ting Ma · 1 shared paper, 2019 · strength 0.06
- Paul J. Ross · 1 shared paper, 2019 · strength 0.06
- Bengt L. G. Glimelius · 1 shared paper, 2019 · strength 0.06
- Thilo Hackert · 1 shared paper, 2019 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.